A putative methyltransferase, YtqB, from B. subtilis was overexpressed, purified and crystallized. X-ray diffraction data were collected from a YtqB crystal to 1.68 Å resolution.
Keywords: Bacillus subtilis, YtqB, methyltransferases, S-adenosyl-l-methionine
Abstract
S-Adenosyl-l-methionine (SAM)-dependent methyltransferases (MTases) catalyze the transfer of a methyl group from a SAM cofactor to specific substrate molecules, including small chemicals, proteins, DNAs and RNAs, and are required for various cellular functions, such as regulation of gene expression and biosynthesis of metabolites. Bacillus subtilis YtqB is a putative SAM-dependent MTase whose biological function has not been characterized. To provide biochemical and structural insights into the role of YtqB in bacteria, the recombinant YtqB protein was overexpressed in the Escherichia coli expression system and purified by chromatographic methods. YtqB crystals were obtained in PEG-containing conditions and diffracted to 1.68 Å resolution. The YtqB crystals belonged to space group P212121, with two molecules in the asymmetric unit.
1. Introduction
Methylation takes place on diverse biological molecules, including small chemicals, nucleic acids and proteins, and participates in a variety of biological processes in all three phylogenetic domains of life: archaea, bacteria and eukarya (Liscombe et al., 2012 ▶). Methylation of DNA or histone is involved in epigenetic regulation of gene expression and aberrant methylation patterns have been implicated in cancer (Varier & Timmers, 2011 ▶; Cheng & Blumenthal, 2008 ▶; Del Rizzo & Trievel, 2011 ▶). tRNA and rRNA are post-transcriptionally methylated mainly at N and C atoms of the base moiety and at O atoms of the ribosyl group in a specific nucleotide position, and their methylation has been shown to modulate RNA stability, translation initiation, mRNA decoding and antibiotic resistance (Motorin & Helm, 2010 ▶, 2011 ▶). Methylation also plays key roles in the biosynthesis of primary and secondary metabolites in cells and can be applied to the production of pharmaceuticals in the pharmaceutical industry (Struck et al., 2012 ▶).
Methylation is catalyzed most frequently by methyltransferases (MTases) in cells. MTases generally deliver the methyl group of S-adenosyl-l-methionine (SAM) cofactor to oxygen-centred, nitrogen-centred, carbon-centred or metal-centred nucleophiles of substrates (Martin & McMillan, 2002 ▶). Based on the tertiary structure of the core fold, SAM-dependent MTases are classified into five main structural families (I–V; Schubert et al., 2003 ▶). Each family possesses structurally unique folds and SAM-binding pocket, suggesting that the five MTase families evolved independently. For example, class I MTases have the Rossmann-like fold in which a β-sheet is flanked by α-helices, and accommodate a SAM molecule in the structurally similar position that is generated in part by the highly conserved acidic residue and GxG motif (Gana et al., 2013 ▶; Liscombe et al., 2012 ▶; Schluckebier et al., 1999 ▶). However, class V MTases contain an SET domain structure, which is folded into three discrete β-sheets that surround a knot-like structure (Del Rizzo & Trievel, 2011 ▶; Qian & Zhou, 2006 ▶; Xiao et al., 2003 ▶). The class V MTases form a hydrophobic channel that places SAM and substrate molecules at its opposite ends.
Bacillus subtilis expresses YtqB, a putative MTase (Kunst et al., 1997 ▶). Secondary-structure prediction proposes that YtqB possesses the Rossmann-like fold of class I MTases. Comparative sequence analyses of YtqB with other class I MTases suggest that YtqB contains the canonical GxG motif and the acidic residue potentially as a part of the SAM-binding site. However, to reveal the exact SAM-binding mode of YtqB, complete structural characterization of the YtqB–SAM interaction is required. Moreover, because YtqB lacks additional domains or N-terminal extensions that generally provide substrate specificity in class I MTases, it is unclear how YtqB recruits its cognate substrate for methylation. As a first step in defining the methylation mechanism and the biological function of YtqB, we have carried out overexpression, purification, crystallization and X-ray diffraction studies on YtqB as described below.
2. Materials and methods
2.1. Construction of the YtqB expression vector
The genomic DNAs of B. subtilis were purified by the Exgene Cell SV kit (GeneAll). The YtqB gene (UniProt E0TY72; residues 1–194) was amplified by PCR from the genomic DNAs using forward (5′-TAAGGATCCGATGATTTTGAAAAAAATTCTTCCTTACAGC-3′; BamHI restriction-enzyme site in bold) and reverse (5′-GCCGATGTCGACTCATTTGCTGATTTGAGCTTTTTTTTCG-3′; SalI restriction-enzyme site in bold) primers. The PCR products and a modified pET49b vector (pET49bm) that contains the N-terminal His6 tag and thrombin cleavage site were digested using BamHI and SalI, and ligated to construct the YtqB expression vector (Hong et al., 2012 ▶; Song & Yoon, 2014 ▶). The ligation products were transformed into Escherichia coli strain DH5α and a correct clone was selected by restriction-enzyme digestion and DNA sequencing.
2.2. Expression of the YtqB protein
The YtqB expression vector DNAs were transformed into E. coli strain BL21 (DE3). Cells were grown at 37°C in LB medium containing 50 µg ml−1 kanamycin until the OD600 (optical density at 600 nm) reached ∼0.8. IPTG was then added to the culture to a final concentration of 1 mM and the YtqB protein expression was induced for ∼17 h at 18°C.
2.3. Purification of the YtqB protein
Cells were collected by centrifugation and sonicated in 50 mM Tris pH 8.0, 200 mM NaCl, 5 mM β-mercaptoethanol (βME), 1 mM PMSF. The cell lysate was cleared by centrifugation (∼25 000g). The supernatant was incubated with Ni–NTA resin (Qiagen) in the presence of 10 mM imidazole at 4°C for 2 h. The resins were applied onto an Econo-Column (Bio-Rad) and were washed using 10 mM imidazole, 50 mM Tris pH 8.0, 200 mM NaCl, 5 mM βME. The YtqB protein was eluted using 250 mM imidazole, 50 mM Tris pH 8.0, 200 mM NaCl, 5 mM βME and dialyzed against 20 mM Tris pH 8.0, 5 mM βME. The His6 tag that is appended to the YtqB protein was removed by thrombin at 18°C for ∼3 h. The YtqB protein was further purified by anion-exchange chromatography using a Mono Q 10/100 column. The column was equilibrated with 20 mM Tris pH 8.0, 5 mM βME and the thrombin-digested YtqB in 20 mM Tris pH 8.0, 5 mM βME was injected into the column. YtqB was eluted using a 0.0–0.5 M NaCl gradient. The YtqB eluate was concentrated to ∼15 mg ml−1 for crystallization.
2.4. Crystallization of the YtqB protein
Crystallization was carried out by the sitting-drop vapour-diffusion method. 0.5 µl of ∼15 mg ml−1 YtqB protein solution was mixed with 0.5 µl well solution in 96-well crystallization plates (Molecular Dimensions) for initial crystallization screening or in 24-well Cryschem plates (Hampton Research) for crystallization optimization and the 1 µl drop was equilibrated against well solution at 18°C. YtqB crystals were initially obtained using the JCSG Core Suite kit (Qiagen) in 30% PEG 200, 5% PEG 3000, 0.1 M MES pH 6.0. The crystallization condition was optimized and modified to 30–36% PEG 200, 5% PEG 2000, 0.1 M sodium cacodylate pH 6.5 or 30–36% PEG 200, 5% PEG 2000, 0.1 M HEPES pH 7.0.
2.5. X-ray diffraction of YtqB crystals
A single crystal in a crystallization drop was directly mounted and flash-cooled under a cryo-stream at −173°C. A total of 360 frames of X-ray diffraction images were collected with a 0.5° oscillation, an exposure time of 1 s per frame and a crystal-to-detector distance of 180 mm using an ADSC Quantum 270 detector on beamline 7A of the Pohang Accelerator Laboratory, Republic of Korea (Fig. 3 ▶). Diffraction data were indexed, integrated and scaled using the HKL-2000 package (Otwinowski & Minor, 1997 ▶).
Figure 3.
An X-ray diffraction image of the YtqB crystal shown with a 1.7 Å resolution ring.
3. Results and discussion
B. subtilis YtqB was overexpressed in an E. coli expression system using BL21 (DE3) strain and was purified to homogeneity in a soluble form by two purification steps of Ni–NTA affinity chromatography and anion-exchange chromatography, yielding ∼4 mg from 1 l culture. In SDS–PAGE analysis, the purified YtqB (calculated molecular weight 21.8 kDa) migrated as a single band between the 15 and 27 kDa standards with a purity of greater than 95% (Fig. 1 ▶).
Figure 1.

SDS–PAGE analysis of the purified YtqB protein (lane 2) and protein standards (lane 1; labelled in kDa).
YtqB was crystallized in PEG solutions at pH 6.5–7.0 (Fig. 2 ▶). Crystals appeared in ∼8 h and were fully grown in ∼24 h. X-ray diffraction data were collected from a single crystal to 1.68 Å resolution (Fig. 2 ▶). A summary of the data-processing statistics is shown in Table 1 ▶. 222 065 observed reflections were merged to produce 43 606 unique reflections with a multiplicity of 5.1, a cumulative merging R factor of 4.8% and a completeness of 99.1%. Indexing, scaling and analysis of systematic absences revealed that the YtqB crystal belonged to the primitive orthorhombic space group P212121, with unit-cell parameters a = 48.87, b = 76.47, c = 100.67 Å. Matthews coefficient calculation indicates that the asymmetric unit contains two copies of YtqB (Matthews coefficient V M of 2.16 Å3 Da−1; 42.9% solvent content; Matthews, 1968 ▶; Kantardjieff & Rupp, 2003 ▶). Analysis of the native Patterson map did not identify any large off-origin peaks, suggesting that there is no translational pseudosymmetry in the crystal. The crystal structures of YtqB alone and in complex with SAM will be described elsewhere. We anticipate that our structural study of YtqB will make a significant contribution to the elucidation of the biological function of YtqB in bacteria.
Figure 2.

YtqB crystals (∼50 × 50 × 400 µm) obtained in 30% PEG 200, 5% PEG 2000, 0.1 M HEPES pH 7.0.
Table 1. Data-collection statistics for YtqB.
Values in parentheses are for the highest resolution shell.
| X-ray source | BL-7A, PAL |
| Wavelength (Å) | 0.9796 |
| Space group | P212121 |
| Unit-cell parameters (Å) | a = 48.87, b = 76.47, c = 100.67 |
| Resolution range (Å) | 20.00–1.68 (1.74–1.68) |
| No. of observations | 222065 |
| No. of unique reflections | 43606 |
| Multiplicity | 5.1 (5.2) |
| Completeness (%) | 99.1 (99.0) |
| R merge † (%) | 4.8 (48.5) |
| R meas ‡ (%) | 5.4 (54.0) |
| 〈I/σ(I)〉 | 41.6 (4.5) |
R
merge =
.
R meas was estimated by multiplying the conventional R merge value by the factor [N/(N − 1)]1/2, where N is the data multiplicity.
Acknowledgments
X-ray diffraction data sets were collected on beamline 7A of the Pohang Accelerator Laboratory, Republic of Korea. This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2012R1A1A1003701 to S-IY) and by a 2013 Research Grant from Kangwon National University (No. 120131874 to S-IY).
References
- Cheng, X. & Blumenthal, R. M. (2008). Structure, 16, 341–350. [DOI] [PMC free article] [PubMed]
- Del Rizzo, P. A. & Trievel, R. C. (2011). Epigenetics, 6, 1059–1067. [DOI] [PMC free article] [PubMed]
- Gana, R., Rao, S., Huang, H., Wu, C. & Vasudevan, S. (2013). BMC Struct. Biol. 13, 6. [DOI] [PMC free article] [PubMed]
- Hong, M., Yoon, S.-I. & Wilson, I. A. (2012). Biochem. Biophys. Res. Commun. 427, 119–124. [DOI] [PMC free article] [PubMed]
- Kantardjieff, K. A. & Rupp, B. (2003). Protein Sci. 12, 1865–1871. [DOI] [PMC free article] [PubMed]
- Kunst, F. et al. (1997). Nature (London), 390, 249–256.
- Liscombe, D. K., Louie, G. V. & Noel, J. P. (2012). Nat. Prod. Rep. 29, 1238–1250. [DOI] [PubMed]
- Martin, J. L. & McMillan, F. M. (2002). Curr. Opin. Struct. Biol. 12, 783–793. [DOI] [PubMed]
- Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. [DOI] [PubMed]
- Motorin, Y. & Helm, M. (2010). Biochemistry, 49, 4934–4944. [DOI] [PubMed]
- Motorin, Y. & Helm, M. (2011). Wiley Interdiscip. Rev. RNA, 2, 611–631. [DOI] [PubMed]
- Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. [DOI] [PubMed]
- Qian, C. & Zhou, M.-M. (2006). Cell. Mol. Life Sci. 63, 2755–2763. [DOI] [PMC free article] [PubMed]
- Schluckebier, G., Zhong, P., Stewart, K. D., Kavanaugh, T. J. & Abad-Zapatero, C. (1999). J. Mol. Biol. 289, 277–291. [DOI] [PubMed]
- Schubert, H. L., Blumenthal, R. M. & Cheng, X. (2003). Trends Biochem. Sci. 28, 329–335. [DOI] [PMC free article] [PubMed]
- Song, W. S. & Yoon, S.-I. (2014). Biochem. Biophys. Res. Commun. 444, 109–115. [DOI] [PubMed]
- Struck, A. W., Thompson, M. L., Wong, L. S. & Micklefield, J. (2012). Chembiochem 13, 2642–2655. [DOI] [PubMed]
- Varier, R. A. & Timmers, H. T. (2011). Biochim. Biophys. Acta, 1815, 75–89. [DOI] [PubMed]
- Xiao, B., Jing, C., Wilson, J. R., Walker, P. A., Vasisht, N., Kelly, G., Howell, S., Taylor, I. A., Blackburn, G. M. & Gamblin, S. J. (2003). Nature (London), 421, 652–656. [DOI] [PubMed]

